|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 281/10 | (2006.01) |
| A61K 31/554 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 5/00 | (2006.01) | ||
| C07D 417/06 | (2006.01) | ||
| C07F 9/6541 | (2006.01) |
| (11) | Number of the document | 2563122 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11775513.2 |
| Date of filing the European patent application | 2011-04-27 | |
| (97) | Date of publication of the European application | 2013-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2016-06-08 |
| (46) | Date of publication of the claims translation | 2016-10-10 |
| (86) | Number | PCT/US2011/034024 |
| Date | 2011-04-27 |
| (87) | Number | WO 2011/137135 |
| Date | 2011-11-03 |
| (30) | Number | Date | Country code |
| 329225 P | 2010-04-29 | US | |
| 328212 P | 2010-04-27 | US |
| (72) |
AQUINO, Christopher, Joseph, US
COLLINS, Jon, Loren, US
COWAN, David, John, US
WU, Yulin, US
|
| (73) |
GlaxoSmithKline LLC,
Corporation Service Company 2711 Centerville Road Suite 400, Wilmington DE 19808,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Cheminiai junginiai |
| CHEMICAL COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 16 | 347.00 EUR |
| 2027-04-27 |